头颈部淋巴结阳性皮肤鳞癌术前PET/CT的价值
单中心病例系列回顾64例无远处转移的头颈部淋巴结阳性皮肤鳞状细胞癌患者,比较术前PET/CT与淋巴结清扫和/或腮腺切除术后的最终病理。PET/CT在颈部阳性预测值为91.1%,颈部与腮腺区阴性预测值均为60%,6.25%患者的手术方案因PET/CT而改变。
要点
- PET/CT对淋巴结阳性HNcSCC-M0特异性与阳性预测值高,但阴性预测值偏低。
- 颈部与腮腺区阴性预测值均为60%,阴性结果不能可靠排除转移。
- 6.25%患者依据PET/CT改变了原CT制定的手术方案。
核心结论
- 对淋巴结阳性HNcSCC-M0手术患者,PET/CT特异性与阳性预测值高,敏感性及阴性预测值相对较低。
- 假阴性组慢性淋巴细胞白血病比例呈升高趋势(66.7% vs 11.1%,P = .09)。
研究设计与样本
- 澳大利亚单中心病例系列,含病历回顾。
- 共纳入64例无远处转移的淋巴结阳性头颈部皮肤鳞状细胞癌患者,术前均行PET/CT。
- 56例行颈淋巴结清扫,30例行腮腺切除术。
主要发现
- 颈部PET/CT阳性预测值为91.1%。
- 颈部与腮腺区阴性预测值均为60%。
- 13例颈清扫和2例腮腺切除是在相应淋巴结区无FDG摄取淋巴结的情况下进行的。
- 假阴性亚组66.7%患慢性淋巴细胞白血病,真阴性亚组为11.1%(P = .09)。
- 6.25%患者的手术方案依据PET/CT结果较术前CT发生改变。
关键数值与推荐
- 颈部阳性预测值91.1%;颈部与腮腺区阴性预测值均为60%。
- 假阴性组与真阴性组慢性淋巴细胞白血病比例:66.7% vs 11.1%,P = .09。
- 6.25%患者手术方案因PET/CT改变。
临床怎么用
- PET/CT阳性结果对颈部淋巴结转移有较高确认价值,可支持手术决策。
- 阴性结果不足以排除区域转移,尤其合并慢性淋巴细胞白血病者需谨慎解读。
局限性
- 单中心、小样本(64例)回顾性病例系列。
- 慢性淋巴细胞白血病比较的P = .09仅为统计趋势,未达显著。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objectives Surgery is the primary treatment modality for node-positive cutaneous squamous cell carcinoma of the head and neck with no distant disease (HNcSCC-M0). The role of preoperative positron emission tomography/computed tomography (PET/CT) scan for these patients is unclear. We compared preoperative PET/CT with final histopathology among patients undergoing lymphadenectomy and/or parotidectomy for HNcSCC-M0. Study Design Case series with chart review. Setting Single Australian center. Subjects and Methods Investigation included disease parameters and preoperative CT and PET/CT findings of 64 patients with node-positive HNcSCC without distant metastatic disease. Fisher's exact test was used to test for a difference in the proportion of patients with chronic lymphocytic leukemia between the false- and true-negative PET/CT subgroups. Results Of 64 patients who underwent PET/CT prior to surgery for node-positive HNcSCC-M0, 56 underwent a neck dissection and 30, a parotidectomy. Of these, 13 neck dissections and 2 parotidectomies were performed in the absence of FDG-avid (18F-fludeoxyglucose) nodes in these nodal fields. The PET/CT positive predictive value of the neck was 91.1%. The negative predictive values in the neck and parotid regions were 60%. Of the false-negative subgroup, 66.7% had chronic lymphocytic leukemia, compared with 11.1% of the true-negative subgroup ( P = .09). Based on PET/CT findings, surgical plans according to preoperative CT were changed for 6.25% of patients. Conclusion Use of PET/CT for surgical candidates with node-positive HNcSCC-M0 has high specificity and positive predictive value with relatively low sensitivity and negative predictive value. A statistical trend toward a higher rate of chronic lymphocytic leukemia among patients with false-negative results is suggested.
引用
- Hirshoren N, Olayos E, Herschtal A, et al. Preoperative Positron Emission Tomography for Node-Positive Head and Neck Cutaneous Squamous Cell Carcinoma. Otolaryngol Head Neck Surg. 2017. PMID: 28925330. doi:10.1177/0194599817731735
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。